<html>
<head>PUBMED IDs for NPM3</head>
<body bgcolor='#C5F0F2'><h1>NPM3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16077960/'>Comparative genomics on FGF8, FGF17, and FGF18 orthologs.</a> August 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16751661/'>Long-term evolution and functional diversification in the members of the nucleophosmin/nucleoplasmin family of nuclear chaperones.</a> June 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17255358/'>Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.</a> January 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19199331/'>Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.</a> May 27  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20073534/'>NPM3, a member of the nucleophosmin/nucleoplasmin family, enhances activator-dependent transcription.</a> April 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20428766/'>AMY2A: a possible tumor-suppressor gene of 1p21.1 loss in gastric carcinoma.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23018034/'>Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics.</a> January 26  2012<br></body></html>
